(Q39500706)

English

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

author name string

Edith Suzarte

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lázaro Gil

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Iris Valdés

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ernesto Marcos

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Laura Lazo

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Alienys Izquierdo

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Angélica García

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lázaro López

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Maylin Álvarez

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yusleydis Pérez

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jorge Castro

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yaremis Romero

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

María G Guzmán

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gerardo Guillén

14

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lisset Hermida

15

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

20 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

International Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

367-379

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

A Protective Role for Dengue Virus-Specific CD8+ T Cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Mouse models of dengue virus infection and disease

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXV011

21 January 2018

Identifiers

10.1093/INTIMM/DXV011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39500706&oldid=1832170780"